ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
Frontiers in Pharmacology (2020) - Comments
doi: 10.3389/fphar.2019.01596  issn: 1663-9812  pubmed: 32038260 

Yu-Li Shen, Yi-ping Jiang, Xiao-Qin Li, Su-Juan Wang, Ming-Hua Ma, Chun-Yan Zhang, Jian-Yong Zhu, Khalid Rahman, Li-Jun Zhang, Xin Luan, Hong Zhang